Search our suppliers catalog
BioVision
BioVision
News about BioVision
Targeting EZH2 to Fight Cancer
Enhancer of Zeste Homolog 2 (EZH2) is a histone methyltransferase that participates in histone methylation and gene silencing. It is overexpressed in many cancers. Several Inhibitors of EZH2 have shown promising anti-tumor activity in clinical trials. For example, EPZ-6438 (Tazemetostat) has been approved by the US FDA to treat epithelioid sarcoma.
Please check the product flyer for more information: EZH2 Inhibitors Flyer
Info BioVision
Products for Life Science research and drug discovery.
BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc.
For more information:
http://www.biovision.com
BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc.
For more information:
http://www.biovision.com
Een moment geduld a.u.b. De resultaten worden opgehaald.
-
Productclonecat nrDownload